Sanabil
VC Fund
Riyadh, Saudi Arabia
Sanabil is a VC fund in Riyadh focused on FinTech and E-Commerce. Sanabil Investments is a sovereign wealth fund specializing in direct and fund of funds investments. Its investments are concentrated in direct equity investments, primarily in the Kingdom, and in funds, as well as in diversified investment portfolios. These investments support the growth of the Kingdom’s economy while building internationalinvestment capability and transferring expertise to local Saudi talent.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 39%
Last updated:
For AI agents: llms.txt
Industries Sanabil invests in
Stages Sanabil invests in
Countries Sanabil invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Pre-Seed
- $100k–$5M
- Series A
- $6.9M–$30M
- Series B
- $1M–$157M
Investment Focus
Industry
- FinTech 9 (13%)
- E-Commerce 9 (13%)
- Artificial Intelligence 9 (13%)
- Information Technology 8 (11%)
- Analytics 7 (10%)
Stage
- Pre-Seed 18 (26%)
- Series B 9 (13%)
- Series A 8 (11%)
- Seed 7 (10%)
- Series C 6 (9%)
Country
- United States 19 (27%)
- Saudi Arabia 17 (24%)
- United Arab Emirates 9 (13%)
- Egypt 5 (7%)
- Oman 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hani Enaya
Head of Venture Capital
|
Head of Venture Capital | Total investments: 3 | Find email | |
| CEO | Total investments: 0 | Find email | ||
Turki Almalik
Deputy CEO & COO
|
Deputy CEO & COO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ImmunoPrecise Antibodies
|
IPA is a biotherapeutic research and technology company that leverages systems biology, multi-omics modeling, and complex artificial intelligence systems to support its proprietary technologies in bioplatform-based antibody discovery. Recently, IPA was ranked by one of the pharmaceutical industry’s most trusted and independent market researchsources as having the highest competitive score for its antibody service portfolio.1The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, providing highly specialized full-continuum therapeutic antibody discovery and development —with advanced omics and complex artificial intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before. Our mission is to provide a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal is to support the advancement of novel biologics against even the most challenging targets, ultimately contributing to the treatment of diseases and the betterment of humankind.Footnote: 1. ROOTS 2022: Antibody Discovery Services and Platforms Market | $21.6M / Post-IPO Debt / Sep 14, 2026 | |
FlyAkeed
|
FlyAkeed is combining multiple definitions into one: "Online Travel Agency", "Travel Management Company", and “Expense Management Solution”. It offers comprehensive travel services and innovative solutions for corporates and their employees to help them achieve the ultimate booking experience when traveling for work. | $25.2M / Venture - Series Unknown / Sep 02, 2026 | |
Qanary
|
Qanary is a digital second-opinion platform designed to help radiologists detect cancer at its earliest, most treatable stages. | $160K / Pre-Seed / Aug 08, 2026 | |
1001 AI
|
1001 AI is building The Sovereign Artificial Intelligence Platform of the Middle East | $30M / Series A / Jun 30, 2026 | |
Aya
|
Aya is a modest fashion e-commerce platform that strives to unite the fragmented modest fashion industry into a single discovery platform. | $6.9M / Series A / Apr 16, 2026 | |
Smart Bricks
|
Smart Bricks make investing in real estate easier, wiser, and more lucrative. | $5M / Pre-Seed / Feb 10, 2026 | |
Safqah Capital
|
Safqah Capital is an innovative fintech and proptech company headquartered in Riyadh. We specialize in structuring and distributing Sharia-compliant Sukuk for small and medium-sized real estate developers. Safqah's digital investment platform enables secure participation from both retail and institutional investors, backed by rigorous duediligence, transparency, and smart governance. Safqah operates at the intersection of technology, finance, and real estate, positioning itself as a key enabler of Vision 2030’s housing and development goals. | $15.2M / Seed / Feb 09, 2026 | |
Simplified Financial Solutions Company
|
Simplified Financial Solutions Company offers startups and SMEs financial management solutions including the ability to issue virtual and physical corporate cards, manage spending and automate expense reporting. | $20M / Series A / Feb 09, 2026 | |
Hala
|
Hala offers a payment and wallet solution for individuals and point-of-sale (PoS) services that enable merchants to accept credit card payments. | $157M / Series B / Sep 15, 2025 | |
Gathern
|
Gathern is a booking platform of private villas, chalets, rest houses, camps, resorts, farms and other places suitable for gatherings. | $71.9M / Series B / Aug 20, 2025 | |
| See all 70 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sanabil invest in?
Sanabil invests primarily in FinTech, E-Commerce and Artificial Intelligence startups, most often at Pre-Seed and Series B stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sanabil's check size?
Sanabil typically joins rounds of $100k–$5M at Pre-Seed, $6.9M–$30M at Series A and $1M–$157M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sanabil participates in.
How do I contact Sanabil?
Public channels for Sanabil include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sanabil?
The team at Sanabil includes Hani Enaya (Head of Venture Capital), Abdullah Alabduljabbar (CEO) and Turki Almalik (Deputy CEO & COO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
